PNC Financial Services Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340 | Hold |
53
| – | – | ﹤0.01% | 4735 |
|
|
2025
Q1 | $188 | Hold |
53
| – | – | ﹤0.01% | 4785 |
|
|
2024
Q4 | $200 | Sell |
53
-43
| -45% | -$162 | ﹤0.01% | 4650 |
|
|
2024
Q3 | $311 | Hold |
96
| – | – | ﹤0.01% | 4622 |
|
|
2024
Q2 | $182 | Sell |
96
-118
| -55% | -$224 | ﹤0.01% | 4680 |
|
|
2024
Q1 | $608 | Buy |
214
+18
| +9% | +$51 | ﹤0.01% | 4468 |
|
|
2023
Q4 | $2.89K | Buy |
+196
| New | +$2.89K | ﹤0.01% | 4100 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$2.93K | – | 4728 |
|
|
2023
Q1 | $2.93K | Buy |
+100
| New | +$2.93K | ﹤0.01% | 4207 |
|